This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Novoheart International Limited. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Innovations by Eugene K Lee in Organoid Technology
Introduction
Eugene K Lee is a notable inventor based in Hong Kong, CN, recognized for his contributions to organoid technology. His innovative work focuses on developing devices that enhance the culture, maintenance, and testing of organoids, which are miniature, simplified versions of organs.
Latest Patents
Eugene K Lee holds 1 patent for his invention titled "Devices comprising organoid chambers and uses thereof to culture, maintain, monitor or test organoids." This patent describes multi-layer bioreactors designed for growing, maintaining, stimulating, monitoring, and testing organoids and tissues derived from hollow organs. The bioreactors are instrumental in modeling disease processes, monitoring disease progression, and assessing biological effects, including therapeutic efficacy and toxicity. Additionally, the patent discloses systems for measuring various parameters of organoid chambers, such as volume, pressure, and contractility.
Career Highlights
Throughout his career, Eugene K Lee has worked with prominent companies in the biotechnology sector, including Novoheart International Limited and Novoheart Limited. His expertise in organoid technology has positioned him as a key figure in advancing research and applications in this field.
Collaborations
Eugene has collaborated with notable professionals, including Kevin D Costa and David D Tran, contributing to the development of innovative solutions in organoid research.
Conclusion
Eugene K Lee's work in organoid technology exemplifies the intersection of innovation and practical application in biomedical research. His contributions continue to influence the understanding and treatment of various diseases through advanced organoid modeling techniques.